Subscribe to Newsletter
Fields & Applications Mass Spectrometry

Putting Pen to Tumor

Many of you will already be well aware of the MassSpec Pen, a handheld MS device capable of nondestructively diagnosing human cancer tissues. In fact, we covered the technology back in 2017 when it began to make headlines. Now, the first diagnostic results have just been published (1) – and they’re pretty exciting.

In case you need a refresher, the device works by dissolving the metabolites from a tumor’s microenvironment in a droplet of water and then analyzing them via MS. The aim is to make surgical cancer removal easier for clinicians by offering a faster, more accurate alternative to tumor margin evaluation than traditional frozen section analysis.

After the pandemic called a halt to testing of the device in surgeries, the team are now back in operating rooms and have used the pen in more than 150 human surgeries so far. 

“These results show the technology works in the clinic for surgical guidance,” said lead author Livia Schiavinato Eberlin in a press release (2). “Surgeons can easily integrate the MasSpec Pen into their workflow, and the initial data really supports the diagnostic accuracy we were expecting to achieve.”

The current study in pancreatic cancer surgery is the first to have results published, but the team plan to continue testing the pen in other cancers, with results expected to be published soon.

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. Mary E King et al., PNAS, 28, e2104411118 (2021). DOI: 10.1073/pnas.2104411118.
  2. UT News (2021). Available at: https://bit.ly/2TFH7rY.
About the Author
Lauren Robertson

By the time I finished my degree in Microbiology I had come to one conclusion – I did not want to work in a lab. Instead, I decided to move to the south of Spain to teach English. After two brilliant years, I realized that I missed science, and what I really enjoyed was communicating scientific ideas – whether that be to four-year-olds or mature professionals. On returning to England I landed a role in science writing and found it combined my passions perfectly. Now at Texere, I get to hone these skills every day by writing about the latest research in an exciting, creative way.

Related Application Notes
FUSION PTR-TOF ABOARD NASA DC-8 FOR ASIA-AQ CAMPAIGN

| Contributed by IONICON

An End-to-End Targeted Metabolomics Workflow

| Contributed by Agilent Technologies

Charge heterogeneity characterisation of an IgG4-based mAb using AEX coupled to MS

| Contributed by YMC

Related Product Profiles
Higher Peaks – Clearly.

| Contributed by Shimadzu Europa

Compact with countless benefits

| Contributed by Shimadzu Europa

The fine Art of Method Development

| Contributed by Shimadzu Europa

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register